The Latest Breaking News on Pharma

Decision means none of drugmaker’s much-trumpeted £650m UK investment package is currently proceeding

Despite ongoing legal battles related to its talc products, Johnson Johnson (NYSE:JNJ) stock has climbed over 23% year-to-date.

Trump's efforts include reshaping drug prices through threats and public shaming.

A handful of biotech stocks are showing renewed strength, with big spikes in their Benzinga Edge Ranking’s Momentum scores over the past week alone.

Sanofi’s market access chief urges ministers to come up with a roadmap to raise spending on new treatments

Revolution Medicines, Inc. (NASDAQ:RVMD) stock is trading higher after the company shared updates from its Daraxonrasib Phase 1 trials on Wednesday.

Instead of making silly statements the government needs to look at why Merck has scrapped its £1bn research centre

AbbVie Inc. (NYSE:ABBV) stock is trading higher on Thursday following an SEC filing that settled litigation with all generic manufacturers, which filed abbreviated new drug applications with the U.S. Food and Drug Administration for generic versions of upadacitinib tablets, marketed by the company as Rinvoq.

Merck, known as MSD in Europe, criticised the UK’s business environment despite the government saying it has become ‘the most attractive place to invest in the world’

Comments by former professor of medicine at Oxford follow scrapping of planned London research centre

UK pharmaceutical sector ‘risks losing investment to other countries’.